Ubs Group Ag Pure Tech Health PLC Call Options Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRTC
# of Institutions
6Shares Held
20.1KCall Options Held
0Put Options Held
0-
Pentwater Capital Management LP Naples, FL16.2KShares$341,5100.01% of portfolio
-
Morgan Stanley New York, NY2.83KShares$59,6210.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX700Shares$14,7630.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY73Shares$1,5390.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $588M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...